On International Women’s Day our Chief Medical Officer, Iris Loew-Friedrich, challenges leaders to step away from perfectionism in order to drive important progress towards equity. 

In a world where digital technology is significantly changing the way patients experience their care, UCB recognized the need for rapid integration of digital innovation into all aspects of business. Read from Emmanuel Caeymaex, Executive Vice President, Immunology Solutions and Head of U.S., on how UCB quickly adapted to the needs of patients and the ever-changing environment by embracing a digital business transformation.

This Employee Appreciation Day, we’re celebrating UCB employees for their unique talents and how they positively impact the lives of the patients we serve. Read from employees, Kassandra Watson and Chris Bess, about how UCB’s culture encourages them to be their authentic self at work.

Last week, UCB released our Integrated Annual Report. 2020 was an exceptional year influenced by exceptional circumstances. Read how we are leveraging our expertise to integrate sustainability into our business approach and improve societal health. 

This Rare Disease Day, we’re continuing to raise awareness about seeing people in need and our commitment to innovating and finding solutions for patients living with rare diseases. 

Today, UCB announced seven U.S-based organizations received support from the UCB Community Health Fund managed by the King Baudouin Foundation in Belgium.

2020 tested many long-held beliefs and practices of how we work, how we think about our health, and how we help others. Read more from UCB's Chief Executive Officer & Chairman of the Executive Committee, Jean-Christophe Tellier, as he reflects on the lessons learned and our work to improve the lives of patients now and to create a healthier future.

While the Boston R&D Hub is relatively young compared to the nearly century-long history of UCB, it represents a continuation and extension of the UCB legacy and our Patient Value Strategy. Read from UCB's Dr. Roger Palframan, Head of External Innovation & U.S. Discovery, on UCB's expanding presence in Boston, Massachusetts and our growing team of talented researchers focused on developing next-generation therapies.

At UCB, we work to foster an inclusive and open environment within our company culture and are continually creating new opportunities for colleagues to foster diverse connections and advance themselves both professionally and personally. Read more about our employee resource group, Women in Leadership (WiL), which exemplifies this passion through its consistent encouragement and promotion of diversity across different functional areas and teams within UCB. 

During Epilepsy Awareness Month, as part of our commitment to providing solutions that positively impact the lives of patients with neurological conditions, we enthusiastically announce a new initiative with Medisafe – the leading integrated medication management platform, personalized to engage patients and deliver outcomes.